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ABSTRACT
Engineering of hard tissues such as bone is a challenge because of the limited
ability of the body to heal large defects. Current treatment options, such as employing
bone sections from the patient or a deceased donor have been utilized for some time
now with various degrees of success. However, these methods still exhibit many
limitations such as limited supply and the possibility of transmission of disease.
To address the many limitations of bone grafts, synthetic engineered substitutes
have been developed and widely researched for nearly three decades. Generally termed
scaffolds, these are matrices that serve the purpose of temporary cell structures to guide
tissue regeneration. A similar area of research, sometimes referred as in-vivo tissue
engineering, is distraction osteogenesis. This is a surgical procedure where the
application of gradual traction to two segments of bone results in new tissue formation
at their interface and it has been utilized for large bone defect reconstruction after
trauma or disease.
This research focused on investigating the novel approach of scaffolds and
distraction osteogenesis in synergy. A biocompatible material was seeded with cells
induced to the bone forming phenotype and a simulated distraction study was
performed to evaluate the ability of cells for in-vitro 3-D mineral deposition. Results of
initial experiments carried out using a custom setup indicate that some degree of
mineralization was achieved but further improvements are still required.
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CHAPTER 1
INTRODUCTION AND BACKGROUND FOR RESEARCH
1.1 TISSUE ENGINEERING
Engineering of tissues is a concept with roots in the mid to late 80’s within the field
of regenerative medicine. It stemmed from the need of a multidisciplinary field aiming
at the development of living tissues for therapeutic applications. Formally, tissue
engineering has been defined as the convergence of previous lines of work in the areas
of clinical medicine, physical sciences as well as engineering and their synergistic
application ―to develop functional tissues that can maintain, restore, or improve
damaged organs‖ [1] for addressing some health issues, particularly the deficit of

Figure 1 - Number of transplantable organs VS number of waiting patients by year for period 19982007
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transplantable organs. According to data in the 2008 annual report provided by the
Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and
Transplantation Network (OPTN), throughout the years there has been a marked and
increasing gap of organs available for transplantation when compared to the number of
awaiting recipients (refer to Figure 1) with at least one fifth of patients dying every year
while waiting [2, 3]. As the number between the demand for transplantable organs
continues to diverge from the number of organs available, tissue engineering could play
a pivotal role providing means of meeting demand and advancing ―the health and
quality of life for millions of people worldwide‖ [4].
1.2 BONE TISSUE ENGINEERING
The lack of transplantable tissue takes importance regarding bone. With life
expectancy rising in the coming decades, the population is projected to grow older with
a consequential increase in musculoeskeletal conditions such as arthritis and
osteoporosis as well as recurrence of injuries to bones, joints, ligaments and tendons
because of trauma or disease [5, 6]. Research reveals that as much as ―500,000 bone
replacement procedures were performed in the United States in 2005‖ [7] and at least 4
million bone grafting surgeries worldwide in the treatment of musculoskeletal
conditions in the same time frame with no signs of the tendency to revert [8]. Paired
with the increased frequency of musculoeskeletal conditions, costs of treatment are also
expected to multiply; in 2004 alone, both direct care expenses and indirect costs–such as
2

losses in productivity and premature death–were estimated at $849 billion dollars with
projected figures to follow this uphill trend [9].
1.3 CURRENT TREATMENTS
Traditionally, musculoeskeletal conditions requiring transplant of bone tissue
have been treated with varying degrees of success with the use of bone autografts and
allografts. Bone autografts– the main source of which is the patient’s iliac crest–have set
the standard providing a datum from which to rate other grafting methods. But even
though ―autologous bone grafts have osteogenic, osteoconductive and osteoinductive
properties‖ [10] providing bone progenitor cells with the ideal environment for
triggering de novo tissue growth, they have also been associated with several widely
documented complications among which infection, pelvis fracture and instability, gait
disturbance, hematoma, abdominal pain, hernia formation, blood loss, tumor
transplantation, nerve damage and donor site morbidity are commonly reported [1113]. In addition, clinical amounts of bone tissue obtained from autologous grafts usually
make this option unfeasible [14].
Bone allografts, on the other hand, virtually overcome the problem of limited
graft material, and they cause neither pain nor morbidity since their origin is cadaveric
bone. Nonetheless, there is a potential risk for bacterial and viral transmission to
recipients. Contamination has been documented for viral diseases such as human
immunodeficiency virus (HIV) and hepatitis B, bacteria such as pseudomonas, serratia
3

marcescens and staphylococcus, other diseases that trigger the autoimmune response and
even signs of diseases without previous record [5, 15]. Rates for contagion oscillate
around 5% but can escalate up to a 50% depending on such factors as the number of
people in contact with the tissue after excision, aseptic technique in harvesting as well
as quality control at varied stages of the tissue banking [16, 17]. And even though the
risk for transmission can be reduced by the introduction of sterilization techniques such
as ethylene oxide, gamma radiation and graft freezing, most processes significantly
decrease the osteogenic capabilities and devitalize the natural properties of the graft
providing yet another reason to disdain this option [5, 18].
1.4 SCAFFOLDS FOR TISSUE ENGINEERING OF BONE
The fact that current grafting techniques, despite their accomplishments, have
been unable to solve the shortage of bone tissue for treatment of large bone losses due
to illness, trauma or aging, has led to interest in the development of alternatives. One
such alternative is the utilization of matrices or scaffolds to support the growth of new
bone tissue.
1.4.1 Overview of Scaffold Requirements
The first mention for the application of resorbable matrices with seeded cells as a
medium for transplantation is acknowledged to Langer and Vacanti in a paper
published in 1988 [19]. Since then, substantial work has been carried out to find the
optimal parameters of scaffolds for bone tissue engineering. Although the complete set
4

of mechanisms occurring in bone formation are not completely understood, several
requirements of scaffolds have been identified that aid in the process. Among these
needs are scaffold biocompatibility to lessen the potential of immunological or
inflammatory response; scaffold material that is degradable [20, 21]; proper scaffold
geometry to match defect site; high porosity in the range from 70 to 90% and with
uniform distribution [22]; pore size from 150 to roughly 700 m with high pore
interconnectivity for nutrient perfusion [23, 24] ; high surface area with the appropriate
chemistry to provide cell attachment; low to nonexistent toxicity to minimize necrosis of
cells [25, 26], and the scaffold should provide temporary mechanical support to
withstand loads upon implantation [27, 28].
1.4.2 Overview of Materials for Scaffold Construction
Multiple research studies have investigated the use of synthetic and naturally
occurring polymers as well as metals and ceramics as scaffold materials for bone tissue
engineering. For instance, Xuebin et al. [29] demonstrated the capabilities of type I
collagen scaffolds in promoting osteoblasts adhesion, proliferation and differentiation
and their potential for osteogenesis both in-vitro and in-vivo. Green [30] confirmed the
presence of binding proteins in scaffolds created using marine sponge skeleton and
their ability to support growth and differentiation of cultured osteoprogenitor cells.
Composite scaffolds using polymeric materials and ceramics such as polycaprolactonecalcium phosphate (PCL-CaP), PCL-calcite (PCL-CaCO3), PCL-hydroxyapatite (PCLHA) or chitin-nanosilica have been shown to be biocompatible [31] and able to support
5

bone cell replication, function and viability [20, 25, 32]. Metals like titanium have also
been employed; one study using TiH2 powder and the sacrificed polymeric sponge
method produced highly interconnected porous and bioactive scaffold with average
porosity of 75% and pore size of 100 to 600 m to mineralize in simulated body fluid
plasma [33]. Nonetheless, most materials investigated fall in the synthetic polymer
category. Poly (L-lactic acid) (PLLA), PCL, polyglycolic acid (PGA), poly(D-L-lactic
acid) (PLDA) and poly(D,L-lactide-co-glycolide) (PLG) scaffolds have been studied for
musculoskeletal tissue engineering applications [34-39].
1.4.3 Scaffold Fabrication Techniques
Several techniques have been used in the fabrication of scaffolds for bone tissue
engineering, many of which have been properly reviewed elsewhere [18, 40, 41].
Conventional techniques such as salt leaching, solvent casting, fiber bonding, phase
separation and gas foaming have been employed to produce porous scaffolds.
Nevertheless, most of these methods lack the ability to create highly interconnected
porous 3-D structures, fail at producing uniform pore size, usually leave solvent
residues, and in the case of salt leaching, limit the construction to small thickness
membranes or wafers [36, 40]. In trying to circumvent many of these limitations,
particularly to achieve control on scaffold inner microstructure [42], solid free form
fabrication (SFF) techniques were introduced in scaffold fabrication. Three-dimensional
printing (3D-P), selective laser sintering (SLS), fuse deposition modeling (FDM) and
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stereolithography (SLA) have been successfully utilized to fabricate scaffolds for tissue
engineering applications [43-51].
Although some success has been achieved, scaffolds created employing all
previously described methods exhibit properties that are still far off from ideal and
prevent their widespread utilization in tissue engineering applications. Accurate
resolution in all building directions, material over cure, range of materials that can be
used due to processing conditions and toxicity of employed materials are issues that
still need further improvement [41, 42, 52].
1.5 CELL MECHANOTRANSDUCTION
The term mechanotransduction was coined to refer to the ability of cells to
respond to different mechanical stimuli such as pressure, fluid shear, stress, and strain
present in their in-vivo environment. This is particularly true for bone cells as the
combination of such events trigger some of the steps involved in the process of in-vivo
bone remodeling by giving cells cues and signals that guide their behavior. As research
suggests [53-57], there is a variety of mechanical signals such as fluid flow, hydrostatic
pressure and substrate deformation that are actively involved in regulating the function
and activity of bone remodeling cells.
Studies have been performed to improve the understanding of the effects that
such mechanical conditions have on bone cells with the aim of better mimicking these
factors on further studies and improving bioreactor designs. The osteogenic potential of
7

mechanical forces on cells has been commonly described. One research study using
polyurethane (PU) scaffolds seeded with rapid mineralizing osteoblasts demonstrated a
cascade of events occurring when scaffolds were subjected to total 5% 1 Hz cyclic bouts
of compressive strain [53]. Increased extracellular matrix (ECM) production with more
uniform distribution, higher mineralization, increased collagen type 1 (Coll-I) and
calcium contents, as well as a minimum twofold increase in osteoblast mRNA markers
such as osteopontin (OPN) and osteocalcin (OCN) were reported. In another study
using HA ceramic scaffolds subjected to mechanical compression regimes, the up
regulation of Coll-I and fibronectin as well as increased production of vascular
endothelial growth factor (VEGF) protein was confirmed [54]. Research carried out by
Rath et. al. employing PCL scaffolds that were subjected to levels of 10% 0.5 Hz
mechanical compression, correlated up-regulation of both Coll-I and of the hydrolase
enzyme alkaline phosphatase (ALP), important during matrix deposition [55].
Other studies using fluid flow perfusion bioreactors to induce shear stress at the
interior of seeded scaffolds have found analogous results to direct mechanical
compression. The team lead by Bancroft [56], demonstrated that compared with static
culture controls, fluid shear ―dramatically improved the distribution of extracellular
matrix‖ through scaffolds made of titanium, observing the highest deposition and
uniformity at peak levels of flow rate. Their findings also suggested that calcium
content was proportional to the rate of flow used. Josef et al. compared calcium
phosphate scaffolds subjected to mechanical stimulation by strain and shear flow to
8

static cultured scaffolds and quantified a 2.5 fold increase in the signaling molecule
prostaglandin E2 (PGE2)–believed to be involved at various stages of osteoblast
differentiation–in the group subjected to shear flow and as much as 80% more PGE2
release in strained scaffolds [57].
Even though no comprehensive study has yet elucidated every parameter,
current research points to the fact that mechanical stimulation provides many of the
signals bone remodeling cells receive that regulate their behavior, activity and function.
1.6 CELL CULTURE
Cell culture refers to the growth of cells obtained from animal or plant tissue in an
artificial environment favorable to maintain their function. Cells might be obtained by
disaggregation of tissue by mechanical or enzymatic action before culture [58]. A major
advantage of cell culture is that this process is commonly carried out inside an
incubator where controlled conditions on the physiochemical environment are
achieved. Control of the pH, osmotic pressure, oxygen (O2) and carbon dioxide (CO2)
levels and ambient temperature are precisely monitored. Likewise, periodic supplement
of the growth medium allows control on the physiological environment, which
provides cells with essential nutrients such as amino acids, carbohydrates, vitamins and
minerals, growth factors and hormones to lead their growth and differentiation [58].
Antibiotics and fungicides are also utilized to maintain the health of the culture by
preventing bacterial and fungi infection or contamination. During the culture period,
9

medium must be regularly changed to replenish the set of nutrients cells are provided.
Also, observations must be made from time to time to assess the general health of the
culture.
As a primary culture reaches confluence, cells need to be sub-cultured or passaged
into a new container with fresh medium to allow continued expansion of cells. Subculture involves detachment of adherent cells to generate a single-cell suspension that
could later be re-seeded at reduced concentrations and give rise to new cell cultures.
Nonetheless, differentiation potential reduces as the number of cell passages increases
and thus, the number of sub-cultures is limited depending on cell type [59]. For the
experiments carried out in this research, first passage bone marrow stromal cells
(BMSC) were utilized. As can be seen on the next page in Figure 2, cells appear
scattered in a T-25 flask after 24 hours of culture. Then, at 96 hours of culture they had
reached confluence. At this point, cells need to be detached from the culture surface by
enzyme action–trypsin is usually utilized for this process–and seeded in new recipients
to continue expansion. The space required for cells to continue growing is also a factor
that depends on the cell type cultured. Some cells will only grow as long as there is free
surface for them to attach while othercell types–such is the case of osteoblasts–might
start forming multi-layer agglomerations.
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A)

B)

Figure 2 - A) Cells cultured after 24 hours. B) After 96 hours in culture, BMSCs reached
confluence.

11

1.6.1 Bone Marrow Stromal Cells (BMSC)
The bone marrow stroma contains different cell types among which endothelial
cells, adipocytes, smooth muscle cells, osteoblasts and stromal fibroblasts are
encountered. Even though extensive expansion is needed for a relevant count of cells to
be obtained, BMSC can be easily isolated by aspirating bone marrow, most commonly
from the iliac crest or femur, and subsequently expanded in-vitro [60, 61].
Experimental evidence suggests that BMSC have a tremendous potential for
differentiation into multiple cell lineages making them candidates in prospective
clinical therapies [60, 62]. For instance, extended periods of in-vitro culture have
demonstrated the capacity of BMSC to form various tissues like cartilage, fibrous tissue,
bone, and muscle, indicating their ability to differentiate into various mesenchymal cell
lineages [62]. In 2000, Woodbury et al. demonstrated that BMSC even have the capacity
to evolve into phenotypes of non-mesenchymal cell types by inducing differentiation of
rodent and human BMSC into neuron cells [63].
Aside from their use in treatment of musculoskeletal diseases, BMSC are also
believed to be useful in several applications like pre-vascularization of implanted
synthetic grafts, as carriers for cell and gene therapy, in the treatment of neurological
diseases and for treating conditions of organs such as the heart, lungs, kidney and liver
[61, 62, 64].
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1.6.2 Medium for Differentiation into Osteoblast Phenotype
The culture of BMSC can be induced towards the osteoblast phenotype. Cues
such as dexamethasone, ascorbic acid and beta-glycerophosphate have been shown to
cause osteogenic induction of cultured BMSC.
Dexamethasone (Dex) is a synthetic glucocorticoid in the steroid drug family that
is commonly used as anti-inflammatory and immunosuppressant [65, 66]. Research
indicates that in BMSC cultures, glucocorticoids like Dex have a potent osteogenic
differentiation effect. One study demonstrated that continuous Dex treatment of
precursor cell lines induced differentiation into bone forming osteoblasts at early days
of culture as measured by increases in mineralization and alkaline phosphatase (ALP)
activity [67]. Moreover, enhanced in-vitro mineralization has been observed in cultures
of human BMSC with Dex along beta-glycerophosphate (β-GP) and ascorbic acid (AA)
[68]. A team in Japan led by Mikami [66], exposed osteoblast-like cells to various
concentrations of Dex in-vitro and for all effective solutions, they observed accelerated
rates of mineralization compared to control cultures.
Ascorbic acid is also identified as a cofactor in cell cultures by intervening in
collagen production and promoting proliferation of various mesenchyme-derived cell
types. Concentrations as low as 250 µM added to cell cultures are shown to positively
modulate proliferation of BMSC while maintaining their differentiation capacity [69].
Similarly, in cultures of human osteoblast-like cells with ascorbic acid 2-phosphate
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(Asc2-P) supplemented medium, significant growth stimulation was achieved and the
ability of cells to deposit 3-D tissue-like material confirmed [70].
Another biochemical factor utilized as osteogenic inductor in culture medium is
beta-glycerophosphate (β-GP), which is added to promote mineral deposition. Coelho
and Fernandes [71] cultured human osteoblast-like cells in Dex only, AA only or β-GP
only medium, in medium with both AA and β-GP, and in medium with all three
reagents. They found that when all three ingredients were present, they collaborated to
the positive differentiation and growth of cells. They observed that AA or Dex alone did
not influence calcium phosphate deposition–as indicated by von Kossa and Alizarin red
staining–but that the presence of β-GP, alone or in combination with the other
supplements did, suggesting its central role in mineralization of formed tissue in-vitro
[71]. Corroborating the role of this compound on mineralization, Fratzl-Zelman et al. [72]
indicated that the absence of β-GP in 4-week old cultures of pre-osteoblastic cells lacked
signs of mineralized material.
1.7 DISTRACTION OSTEOGENESIS
Distraction osteogenesis is an orthopedic technique based on the application of
mechanical traction between two segments of bone in order to induce new tissue
formation at their interface. In 1905, professor Codivilla first described this
breakthrough method of applying the traction force directly into the skeletal system
and its successful implementation in lengthening lower limbs from 3 to 8 cm in several
14

patients [73]. However, the procedure did not gain clinical relevance until the work of
Dr. Ilizarov [74] who in 1951 formulated the Law of Tension-Stress after noting that
―gradual distraction on living tissues created stresses that stimulated and maintained
active regeneration‖ [74] which also led him to the development of a distraction
apparatus bearing his name. From then on, distraction devices have been designed and
employed in limb lengthening and reconstruction as well as treatment of other
conditions such as axis correction and craniofacial malformations [75-77].
The

procedure

has

been

successfully

employed–despite

the

risk

for

complications such as osteomyelitis, fracture and infection–in reconstruction of large
defects of long bones in human patients affected by trauma or congenital diseases [7880]. Similarly, clinical studies have been carried out to correct facial asymmetry on
patients with both automatic and manually operated devices with results of over 10 mm
of new bone tissue formed [81, 82]. Other studies in animals have investigated different
distractor designs and rates of application also with good clinical outcomes [83, 84]
demonstrating the potential for bone formation in-vivo.
Bone transport is the basic principle of distraction osteogenesis, which consists of
the application of an incremental pull to set apart two bone segments after a larger
section is osteotomized (cut in two). The continuous application of traction on one
segment of bone, while maintaining a stable fixation on the site, drives cells towards
deposition of a new layer of soft tissue that precedes mineralization and ultimately
actual bone formation.
15

Protocols utilized in clinical practice and/or animal models, allocate a recovery
or latency period of several days to one week, after the osteotomy is performed, to
allow the proper callus or soft tissue to develop. Then, incremental pulls in the range of
0.5 to 1 mm every 24 or 48 hours are applied increasing the volume of soft tissue
formed. This pattern is continued until the desired length of new bone has been
achieved. To finalize, the patient undergoes a consolidation period, in the scale of
weeks, in order for the bone segments to fuse, mineralize and become dense prior to full
weight bearing [78-80, 83-86]. The sequence of images shown in Figure 3, taken from
[87], depicts the process of distraction osteogenesis in a femur rat model. Radiographs
a) through c) were taken at days zero, 10 and 21 after the osteotomy respectively. The
next two radiographs were taken 7 and 21 days after distraction and the last after pins
removal and bone consolidation.

Figure 3 – Process of Distraction Osteogenesis in a white rat femur model. Reproduced from [87].
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CHAPTER 2
RESEARCH AIMS AND HYPOTHESIS OF THE STUDY
2.1 INTRODUCTION
This research will focus on investigating the results of the synergistic application
of both osteoblast seeded scaffolds and simulated in-vitro osteodistraction. Based on the
literature reviewed in the previous chapter, a hypothesis is formulated indicating that
three-dimensional tissue formation at the interface of two pre-seeded matrices–whether
natural graft or synthetic material–might be possible and strongly influenced when
subjected to the in-vitro distraction regime. The fact that clinical outcomes of distraction
osteogenesis have been positive for numerous documented in-vivo cases, allows the
conclusion that new tissue formation might also be possible in-vitro using the proper
cell culture and growing conditions.
Despite the many efforts taken in trying to mimic the conditions in-vivo, it will
be impossible to achieve all signaling and mechanisms occurring in the human body
when bone is remodeling and hence, actual bone formation in-vitro is not very feasible
under the setup to be utilized. Nonetheless, it is possible for this experiment to
demonstrate the ability of osteoblast cells to construct mineralized 3-D structures that
closely resemble mineralized tissue. Also, this model should provide a better
understanding of the conditions and factors that cells undergo while the process of
bone formation occurs in order to further improve bioreactor design and culture
techniques. Furthermore, if positive results are obtained, future iterations of this setup
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could become implemented in the culturing and growing of safe and fully
biocompatible human tissue.
2.2 AIMS OF THE EXPERIMENT


Design a platform for parallel testing of samples in a simulated in-vitro
distraction osteogenesis.



Study the effect that a simulated distraction regime has on PCL scaffolds seeded
with BMSC.



Study the potential of BMSC to deposit and mineralize 3-D tissue in clinically
relevant amounts.

2.3 HYPOTHESIS TO TEST


The in-vitro simulated distraction osteogenesis regime might drive cells towards
increased deposition of mineralized ECM that could allow growth of relatively
large 3-D constructs closely resembling bone tissue.

In order to test the feasibility of the hypothesis formulated, a plan of action was
devised. This plan consisted on performing a mechanical procedure that resembled
distraction osteogenesis in an in-vitro model. The distraction regime was carried out on
PCL scaffolds fabricated via salt leaching technique, which had been previously seeded
with BMSC induced into the osteogeblast lineage. After the distraction procedure was
finalized, the Alizarin red marker for calcium was added into the scaffolds to assess, in
a qualitative manner, if mineralization had occurred. The process flow shown in Figure
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4 depicts the major steps of the culturing process and the distraction regime.
Methodology and experiments are described in detail in the following chapters.

Figure 4-Process flow of the main steps in the Experiment
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2.4 THESIS OUTLINE
This thesis is organized in 5 chapters. As presented already, Chapter 1 provides
background and an overall literature review on the current state of tissue engineering as
well as the concept of distraction osteogenesis. This chapter provides figures that
support the claim for engineering of tissues and general information on the medical
procedure that is attempted to replicate in-vitro. Chapter 2 provides the hypothesis that
will be tested as well as a process flow depicting the major steps in the experiment
setup. Chapter 3 will discuss information on the design and development of a platform
suitable for in-vitro testing focusing on the needs of common culture procedures and
properties necessary for cell growth. Chapter 4 continues with the description of the
qualitative experimentation on cell culture, both in the proposed regime and on the
static culture utilized for control. Finally, Chapter 5 gives the overall findings of the
experiment and provides reference to upcoming work that can be addressed for
improving the results of further experiments.
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CHAPTER 3
EXPERIMENTAL SETUP FOR IN-VITRO DISTRACTION
OSTEOGENESIS
3.1 INTRODUCTION
This chapter presents information on the materials selected for scaffold
fabrication and details on their construction. Also, based on the requirements for cell
culture, the implemented setup for in-vitro distraction osteogenesis is presented along
with the process for designing and building of a proper tool for in-vitro
experimentation. Later, Chapter 4 will present details on the culturing experiments and
assays utilized for assessing mineralization.
3.2 SETUP FOR IN-VITRO DISTRACTION OSTEOGENESIS
The culture of cells requires a sterile environment for cells to properly grow and
maintain function. On the in-vitro distraction regime, there was a need to seed two
scaffolds, bring them into contact at their seeded surfaces, culture for a period of time
and progressively increase the gap separating the scaffolds’ contact surfaces. With this
purpose in mind, a platform had to be designed that permitted the implementation of
this simulated regime while maintaining the appropriate cell culture conditions.
3.2.1 Incubation Conditions and Application of Linear Displacement
For the in-vitro distraction regime, application of precise and continuous
movement was needed. For this reason, a BOSE ElectroForce BioDynamic® mechanical
tester was fitted inside an Excella ECO-170 incubator. This setup would allow
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controlling the distraction regime while maintaining culture conditions of 37 ˚C
temperature and 5% CO2. The factory setup of the ElectroForce BioDynamic® was
slightly modified leaving in place the main grips to which a platform for
experimentation–described in detail later–would be attached. An actuator connected to
a transducer provided the linear displacement required. The force-measuring or load
cell was detached to properly fit the ElectroForce BioDynamic® inside the incubator.
3.2.2 Win-Test 4.1 Software
The proprietary software WinTest® version 4.1 was utilized for controlling the
ElectroForce BioDynamic® using a PC running Windows® XP. According to the
manufacturer, this software comprises an integrated solution for PCI control and data
acquisition within an easy-to-use and intuitive interface–the main window of the
application is shown in Figure 5–with real time readings. Among the many options this
software provides is the ability to interface with the used test instrument to apply
varied load and displacement patterns to specimens allowing study of their material
properties such as fatigue.
By selecting displacement as input feedback, the linear actuator can be driven
into various waveforms including sinusoidal, ramp, square and triangle. For the
purposes of this experiment, the ramp waveform was utilized. This pattern generates
downward motion of the lower grip from one position to another. The rate of
displacement, measured in millimeters per second (mm/sec), can be defined according
to each experiment’s needs. A factory lower limit on this rate is set at 6.5E-6 mm/sec,
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making very precise displacement possible. This fact was used to the advantage of this
experiment since fine motion of the system, in the micrometer range, was required to
simulate distraction. Using the capabilities of this hardware-software combination, a
schedule was prepared to carry out the simulated distraction regime as described in the
in-vitro experimentation sections of Chapter 4.

Figure 5 - Main interface of the WinTest® 4.1 software.
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3.2.3 Design of Platform for In-vitro Osteodistraction
Because the main requirement in cell culture experiments is the ability to
maintain sterile conditions, a device was designed and constructed to offer this degree
of hygiene while still providing a platform for the linear displacement to be applied. A
modular design was implemented that consisted of several parts presented below in
Table 1.
Table 1 - List of parts for the modular design of
the platform.

Part Name

Quantity

Vial Cap

4

Upper support platform

1

Inner pistons

4

Vial holders

4

Connecting rods

4

Lower support platform

4

Moving platform

1

As can be seen in the computer aided design (CAD) model of Figure 6, the vials
containing the pre-fabricated scaffolds attached into holders. The holders in turn,
coupled to the moving platform, by means of 4 connecting rods, which finally
assembled to the ElectroForce BioDynamic® lower grip. Atop each vial, a cap with two
orifices was placed to provide means of periodically changing the medium during
culture. These vial caps were connected to the main support structure which held
statically from the top as it fastened to the upper grip using a compression nut. The caps
also supported a piston that dropped into the vial, each one holding a porous scaffold.
The main structure consisted of both upper and lower support bases with guiding
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sleeves to maintain the vials in position. The support bases were fixed to one another by
3 rods. Also, 4 screws, serving as guides, were attached to the moving platform leaving
one nut per screw free to move. This was done to hold the position of the platform, and
hence of the gap separating scaffolds, between periods of distraction and latency. All
parts were constructed using an available 3-D systems’ uPrint 3-D printer–which
utilizes ABS plastic–and attached together using nuts and # 6-32 screws of various
lengths. The CAD was modeled in Pro-E version 4.0 and it is shown below in Figure 6.

Figure 6 - CAD model of the platform for simulated distraction
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3.3 SCAFFOLD FABRICATION
For this study, scaffolds needed to fulfill the two basic requirements of
biocompatibility, to allow cell attachment, and low degradation rates to maintain its
shape during the length of the experiment. Internal porosity was not of utmost
importance since cell penetration and survival at the interior of the scaffold was not the
focus of this study. Rather, seeded cells were needed to attach into the upper surface of
the scaffolds to facilitate interaction and function at the interface of two samples. In this
fashion, continuous cell deposition of layers of ECM might be achieved along with the
formation of mineralized tissue. After some research, Poly-ɛ-caprolactone was selected
as the scaffold fabrication material due to its characteristics, and salt leaching was the
employed method since it is an easy and inexpensive technique. The fabrication steps
are explained next.
3.3.1 Poly-ɛ-Caprolactone (PCL)
Poly-ɛ-caprolactone is an aliphatic polyester that has been termed safe for use in
human experiments. Due to the many properties it exhibits, PCL has been used in
various applications like fabrication of scaffolds for tissue engineering, adhesives and
food packaging [36, 88-90]. It has also been termed safe for medical applications, such as
drug delivery devices, by the FDA [91, 92]. Furthermore its mechanical properties such
as tensile strength and Young’s modulus–a set of properties is summarized in Table 2–
along with its capacity to slowly biodegrade, make PCL a choice in implantable devices
and other medical applications [93]. The PCL utilized for this experiment was obtained
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from Sigma-Aldrich in the form of small pellets and had a stated average molecular
weight (Mw) of 80,000 Daltons.
Table 2 - Properties of PCL. Reproduced from [93]

Properties

Range

Number average molecular weight (Mn/g mol-1)

530-630,000

Density (ρ/ g cm-3)

1.071-1.200

Glass transition temperature (Tg/˚C)
Melting temperature (Tm/˚C)

(-65)-(-60)
56-65

Decomposition temperature (/˚C)

350

Inherent viscosity (ƞinh/cm3 g-1)

100-130

Intrinsic viscosity (ƞ/cm3 g-1)

0.9

Tensile strength (ơ/ Mpa)

4-785

Young modulus (E/GPa)

0.21-0.44

Elongation at break (ɛ/ %)

20-1000

3.3.2 PCL Degradation Study
As recalled from the literature reviewed, one of the requisites of scaffolds is their
ability to maintain their shape from the time of implantation up to the required length
of time tissue takes to regenerate. Similarly, for this experiment, the shape of scaffolds
needed to remain with minimal modification to keep the most possible area of contact
during a simulated latency period in the experiment. Furthermore, since degradation of
the polymer also affects the pH of the medium, making sure the polymer degraded
slowly was also required to preserve the proper medium acidity and hence its positive
effect on cells.
In general, the higher the molecular weight of the polymer, the higher the
degradation time. This was the reason to utilize a polymer with a relatively high
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molecular weight. The properties of the PCL utilized were confirmed by performing a
gel permeation chromatography (GPC) analysis as follows. First, 0.25 grams of PCL
were dissolved using tetrahydrofuran as solvent. Then, 200 μL of this solution were
injected in a Viscotek TDA 302 Triple Detector Array. This apparatus measures and
compares the refractive index of the polymer relative to that of the solvent. As can be
seen in the graph of Figure 7, the software generates a plot of the refraction index
versus the volume analyzed. Then, it computes the area below the curve to provide a
measure of the molecular weight of the compound analyzed in units of Daltons (Da).
The results of this study confirmed that the molecular weight (Mw) was relatively close
to the value of 80 kilodaltons (kDa) expressed by the manufacturer which confirmed
that degradation should be minimal for this material. Table 3 reproduced from the
information of the experiment, lists the properties found for the polymer.
To further support the analysis, three sample scaffolds (porous type) were
analyzed for weight changes for a period of 3 weeks. The scaffolds were incubated at 37
°C and 5% CO2 in phosphate buffer saline (PBS) since it approximates the pH of the
medium used in the cell culture experiments. The initial weights were recorded and
then each scaffold submerged in excess PBS. At days 7, 14 and 21, their weights were
again recorded after drying inside an oven for one hour. The weight of scaffolds
remained virtually unchanged during the time of culture further indicating the slow
degradation rate of the PCL utilized, as shown in Figure 8.

28

Table 3 - Results of GPC Analysis.

Multi-Detectos Homopolymers: Results
Peak RV - (ml)

4.833

Mn - (Daltons)

18315

Mw - (Daltons)

74545

Mz - (Daltons)

2.18E+08

Mp - (Daltons)

23931

Mw/Mn

4.070

Percent above Mw: 0

0.000

Percent below Mw: 0

10.108

IV - (dl/g)

1.0571

Rh - (nm)

6.980

Rg - (nm

No calc

Wt Fr (peak)

1.000

Mark-Houwink a

0.800

Mark-Houwink logK

-3.419

Brances

0.000

Branch Freq.

0.000

RI Area - (mvml)

69.5

UV Area - (mvml)

0

RALS Area - (mvml)

44.79

LALS Area - (mvml)

28.84

DP Area - (mvml)

1214.99

Figure 7 - Curve of refractive Index VS volume analyzed generated
by the GPC Analysis.
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Figure 8 - Degradation behavior of PCL scaffolds.

3.3.3 Salt Leaching
Scaffolds were fabricated utilizing the simple and affordable technique of salt
leaching (SL). This method produced scaffolds that were appropriate for culturing of
cells, even though they exhibited a non-uniform pore distribution. Two variations of the
SL technique were utilized based on two types of scaffolds needed.
One scaffold type was directly cast to the glass vial to create a solid bond hence
keeping the scaffold in place during simulated distraction. This was achieved by
pouring four grams of PCL pellets and melting the material by heat conduction for
approximately 30 minutes. After the PCL had melted into a clear and viscous substance,
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0.25 grams of sodium chloride salt (NaCl), sieved to a particle size of about 300 µm,
were added per vial to act as pore generators (porogens) at the uppermost surface of the
PCL. As the vials cooled, the excess salt was removed and once the PCL had completely
solidified, the vials and their contents were submerged in ultrapure water for 72 hours
with water changes taking place roughly every 8 hours. After the salt dissolved, it
resulted in a substrate adhered to the vial with a highly porous upper surface. Figure 9
A) depicts the process utilized in the fabrication of this type of scaffold (vial scaffold).
The second type of scaffold (porous scaffold) was fabricated using a more
traditional technique following a slight modification to the method presented by [36].
As depicted in Figure 9 B), scaffolds were fabricated by dissolving 1 g of PCL on 10 mL
of chloroform inside a chemical hood. The PCL pellets and chloroform were manually
stirred in a beaker for 45 minutes until a uniform viscous mixture developed which had
a concentration of 10 % (w/v). Next, 7 g of NaCl sieved particles were added to achieve
a PCL to salt weight ratio of 7:1. At this point, the slurry that formed was poured into
pre-fabricated plastic molds of 10 mm diameter and 5 mm thickness that were covered
with aluminum foil for easy detachment. Then, molds were left for over 24 hours under
the chemical hood at which point the PCL had solidified, entrapping the salt particles,
and chloroform evaporated. Next, scaffolds were detached from the molds and
submerged in ultrapure water for over 72 hours for the salt to dissolve. After this time,
the scaffolds appeared floating over the water serving as an indicator that salt had
completely dissolved.
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Figure 9 - Process for scaffolds fabrication. A) For scaffolds attached to the vial. B) For porous
scaffolds to be fixed to the inner piston.
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3.4 SCAFFOLD CHARACTERIZATION
3.4.1 Microscopy Observations
After the scaffolds were washed in distilled water for over 72 hours, one sample
of each type was removed and analyzed at its outer surface by using light microscopy.
This was done to assess that scaffolds exhibited the proper morphology, suitable for cell
culture experiments, in the exposed or external surfaces. Observations were made using
a Carl Zeiss Axiovert 40 CFL microscope. The examination indicated the presence of a
PCL matrix with interconnected voids or pores with a size of roughly 300 µm, the same
as the sieved salt particles. This porous morphology was observed at the surfaces of
both types of scaffolds fabricated. For the observations of the melted PCL scaffold, the
vial was broken to expose the porous surface. The images of Figure 10 depict the
observed surfaces indicating the size–as measured using the microscope software–of
the pores in the appropriate range.
3.4.2 -CT Scanning of Porous Scaffolds
Followed by observations under the microscope, a more comprehensive
visualization of the scaffolds was required to have a description of their internal
architecture. With this purpose in mind, a sample scaffold was left drying inside an
oven for 45 minutes and then scanned using a SCANCO Micro-40CT, -CT scanner.
Using the scanner’s standard resolution, the process took around one hour and it
provided high-resolution images of the scaffold’s structure. The output was given as
320 slides with a thickness of 16 m that were saved as a sequence of TIFF images.
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Figure 10 - Microscopy observation of scaffolds. The upper image corresponds to the
porous surface of melt scaffolds. The lower image shows surface of porous salt leached
scaffolds.
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The internal porosity of the scaffold, as mentioned before, was not truly
important for this study. Nonetheless, a CAD reconstruction of the scanned images was
performed solely to have a better description of the porosity and internal architecture of
porous scaffolds. This was performed using the software Mimics® version 14.0 as
described next.
3.4.3 Scaffold 3-D Reconstruction and Porosity Analysis
Mimics® provided the means of selecting, in a slide by slide fashion, the material
of interest to reconstruct based on the sequence of TIFF images. Once the set of images
had been imported, the brightness and contrast in the working environment were
adjusted. Then, upper and lower threshold values were chosen to select a uniform type
of material throughout all slides. All regions in each slide falling within the threshold
values were selected although manual editing of each layer was needed in some
regions. The upper and lower threshold values utilized were -849 to -638 units. The
thresholding process is shown in Figure 11–two upper and lower left images–where the
green color indicates the scaffold material (PCL) selected for reconstruction as seen
from the top, right and posterior views.
Once the sections of PCL material had been selected in each slide, the 3-D
reconstruction was done in a relatively simple way just by selecting the quality of the
construct. For the means of this experiment, the capabilities of the computing
equipment restricted quality to medium setting. Nonetheless, this resolution permitted
good observations of the inner morphology of the scaffolds while allowing a porosity
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analysis to be carried out. The 3D reconstruction of the scaffold is shown in the lower
right image of Figure 11.

Figure 11 - Process of “thresholding” and 3-D reconstruction using Mimics 14.1

Using a built-in pore measurement function in Mimics®, it was possible to
calculate the porosity in sixteen samples taken out of the reconstructed scaffold model.
The reason for this was due to restricted memory and processing power of the
computer utilized which prevented making the analysis on the whole scaffold. Hence,
sixteen cubes of the same size (2.5 mm3) were selected randomly throughout the
scaffold–upper image of Figure 12–for analysis. The cubic sections were analyzed using
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this function and the averages calculated yielding mean porosity of 45.8%, with
standard deviation of 7.08, and 100% average pore interconnectivity. These values were
taken as representative for the whole scaffold structure and for all porous scaffolds
fabricated. Table 4 summarizes the results of the pore analysis.
Table 4 - Porosity analysis on fabricated scaffolds.

3D Section

Porosity (%)

Pore Interconnectivity (%)
100

Cube-1

45.41

Cube-2

34.54

100

Cube-3

38.19

100

Cube-4

42.78

100

Cube-5

49.78

100

Cube-6

52.41

100

Cube-7

49.46

100

Cube-8

53.98

100

Cube-9

41.63

100

Cube-10

30.29

100

Cube-11

46.57

100

Cube-12

55.6

100

Cube-13

50.41

100

Cube-14

42.58

100

Cube-15

50.41

100

Cube-16

49.11

100

Average

45.82

100.00

Std Deviation

7.08

0.00

In a close-up view at the 3-D reconstruction–shown below in Figure 12–of a
section of the whole scaffold, the inner morphology can be appreciated more clearly.
This image demonstrates there are pores of various sizes less than 300 µm. Also, the
pores appear highly interconnected in accord with the calculations made using
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Mimics®. Some voids in the PCL matrix with the shape of salt crystals, are visible in
this cut through plane and indicated by dark arrows.

Figure 12 - Upper: 16 cubic sections selected for pore analysis. Lower: close-up view of
inner microstructure where pores can be identified (black arrows).
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3.5 CONCLUSION
This chapter presented the methodology for the design and implementation of a
setup for testing the hypothesis of in-vitro osteodistraction. Using tools available, it was
possible to design and assemble a platform that permitted similar conditions of cell
culture while also providing means for implementing an in-vitro distraction regime.
This platform was designed to complement into an apparatus that provided control of
linear movement to simulate distraction (gap increase). Upon testing of this system, it
was seen that indeed the gap could be increased very smoothly over long periods of
time. Also, chemical and physiological conditions were achieved by fitting the whole
setup at the interior of an incubator. Moreover, two different types of scaffolds, to be
utilized in cell seeding experiments, were produced following the simple technique of
salt leaching. Microscopy observations and -CT reconstruction as well as a GPC
analysis of the PCL utilized for their construction, indicated scaffolds exhibited
properties suitable for cell culture experiments.
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CHAPTER 4
METHODOLOGY FOR CELL CULTURE EXPERIMENTS
4.1 INTRODUCTION
Three cell culture experiments were carried out each with a purpose in mind.
First, one cell culture experiment was performed to assess the biocompatibility of PCL
and its ability to support growth and function of BMSC. In this experiment, maturation
and viability of BMSC was evaluated by inspecting for calcium deposits. Both second
and third experiments were carried out as the in-vitro osteodistraction model and its
corresponding static control. BMSC utilized were harvested from the bone marrow
extracted from white rat femurs as described by [94]. Two medium preparations, one
containing dexamethasone (+Dex) and the other without it (-Dex), were prepared
according to a recipe borrowed from [94]–refer to Appendix 1–and utilized for cell
culture. The experiments are described in detail in the following sections.
4.2 CULTURE TO EVALUATE SCAFFOLD MATERIAL BIOCOMPATIBILITY
In this experiment, minimum essential medium without dexamethasone (α-MEM
–Dex) was utilized. BMSC cryogenically preserved in a vial at a concentration of 106
cells were reanimated following a standard protocol as follows. First, the vial was set
under running warm water until the solution completely liquefied. Then the cell
suspension was aspirated using a pipette and deposited into a T-25 flask for culturing.
Four mL of –Dex medium, warmed to 37 °C, were added to the flask to provide
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nutrients and left incubating overnight. After 24 hours, surviving cells were observed
under the microscope and the medium was changed to allow continued cell growth
until they achieved confluence. Once cells had reached that level of growth, trypsin was
added to the flask with subsequent incubation for 5 minutes for cells to detach.
Followed by two rinses in phosphate buffer saline (PBS) and the addition of 5 mL of
new medium into the flask, the whole cell suspension was aspirated and seeded into
five scaffolds (1 mL per scaffold). This process was accomplished by depositing the
solution drop by drop into the upper surface of the scaffolds. The scaffolds had been
previously fixed to the bottom of a well plate by using autoclaved silicone. Then, the
well plate was put inside an incubator at 37 °C and 5% CO2. The culture medium was
changed every two days at a volume of 1 mL per well. Under these conditions, scaffolds
were cultured for a period of 24 days.
At various days through the culture period, cells were observed to qualitatively
evaluate if the PCL scaffolds had an effect on cell viability. Also, the xylenol orange
(XO) assay for calcium deposition was performed to observe if cells had reached their
mature phenotype and continued function.
4.2.1 Results of Material Biocompatibility Experiment
Seeded cells that did not adhere to scaffolds were observed at the surface of the
well plate. Images taken at various points of time during culture, demonstrate that the
PCL had little effect on the cells as they continued growing until reaching confluence.
As can be appreciated in the images in Figure 13 next page, taken using both the 5x and
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10x microscope objectives, cells remained alive in the presence of the scaffold material
and a very particular behavior was observed in which cells formed larger
agglomerations next to the scaffold wall proving the biocompatibility of the material.

Figure 13 - Live cells next to scaffold material at 24 and 72 hours after
seeding respectively. The dark regions correspond to the scaffold wall.
Photographs taken using the 5X and 10X objectives, respectively. In the
pictures, some cells appear already attached–elongated bodies–while others
still float in the medium resembling small dots.
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Employing only optical microscopy, it was not possible to observe cells adhered
into the scaffold since the PCL did not offer a good contrast for cells to be seen. For this
reason, after 18 days of culture, the XO marker was utilized to have an indication of
whether cells had continued to grow and differentiate in the presence of scaffolds. XO is
a fluorochrome that binds to calcium deposits and fluoresces with a heavily red-orange
coloration when observed under a microscope at specific wavelengths of 440/570 and
610 nanometers [95]. The indicator has been successfully utilized in determining
calcium nodules in in-vitro cell cultures as well as in-vivo studies using small (rat,
rabbit, chicken) and large (sheep, dogs) animal models [96, 97]. XO offers an advantage
over other fluorochromes such as Von-Kossa and Alizarin Red since it can be used
without the need to end the culture (fixation of cells) as it does not have deleterious
effects on cells [95]. Since this study evaluated continued cell function past 18 days of
culture, XO was a suitable indicator of osteoblast phenotypic activity of cultured BMSC.
In this assay, the XO was added to the seeded scaffolds on days 18 and 24 of
culture. On both days, medium was changed and 1 µL of XO was added per milliliter of
medium using the same concentration (20 µM) presented by [95]. Then, the cells were
further incubated overnight and observed on the following day after the old medium
was replaced by fresh one. Again, observations were carried out using a Carl Zeiss
Axiovert 40 CFL microscope which was fed with fluorescent light by using a HBO 50
mercury lamp. All pictures were obtained using a Carl Zeiss AxioCam MRC attached to
the microscope using the 5x objective.
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Figure 14 - Xylenol Orange assay for Calcium deposition. A and B taken at days 18 and 24 respectively. C and D
show the same area, on day 24, photographed by adjusting the focus to two different depths. Calcium nodules are
present indicating cells had penetrated and continued mineralizing.

In this experiment, the pictures indicated that even though cells had been
cultured with medium lacking dexamethasone (-Dex), nonetheless the osteoblast
phenotype had been reached since some calcified nodules were present within the
structure of the scaffold as can be seen in images A) and B) of Figure 14. The results also
demonstrated that the fabrication process yielded scaffolds that were biocompatible as
confirmed by its ability to support continued cell function and growth. Moreover,
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photographs taken after day 24 showed that cells had penetrated and formed calcium
into varied layers within the structure of the scaffold. This can be seen in serial images
C) and D) of Figure 14. These two images depict a single section of the scaffold
photographed two times by adjusting the focus to a different depth for each
photograph. Calcium nodules (orange dots) are observed on both layers shot indicating
cells had matured into osteoblast and had attached to internal surfaces of the scaffold.
4.3 SIMULATED OSTEODISTRACTION EXPERIMENT
For this experiment, cells were seeded directly in the scaffold that had been
created inside the vial by melting and salt leaching. Prior to this step, several measures
were taken to guarantee proper hygiene and to enhance the chances for cell survival
and attachment. After seeding, the porous scaffold was set into contact with the seeded
surface and cells were incubated in this configuration for two weeks. A proper static
control with both 3-D scaffolds and static surface culture was used as comparisons to
the results obtained from this experiment. The following sections describe the
methodology followed.
4.3.1 Scaffold Washing and Pre-wetting
As a first step, scaffolds were rinsed using distilled water and two concentrations
of alcohol, 70% and 95% respectively. The three washes were done for ten minutes in
each solution. Next, the scaffolds were put inside an oven at 40 °C for roughly one hour
which ensured that most water, absorbed by scaffolds during salt leaching and
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washing, had evaporated. Then, for a period of approximately four hours, scaffolds
were pre-wetted by submerging them in +Dex culture medium to allow proteins and
other substances that promote cell adhesion to coat the surface of the scaffold hence
improving the ability of cells to attach. At this point, scaffolds were ready for cell
seeding and culture started. Figure 15 shows a photograph of the porous and the vial
scaffolds at the interior of the oven.

Figure 15 - Porous scaffolds drying inside oven at 40° Celsius.

4.3.2 Sterilization Precautions
Established guidelines such as cleaning all surfaces with 70% ethanol and UV
radiation were followed to guarantee sterile conditions inside the biological hood prior
to using it. Similarly, the pieces of the platform constructed for testing were put inside
the biological hood and treated for some time with UV light. This process was done for
over five days to make sure most surfaces were free of any bacteria or microbes that
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could contaminate the experiment at the moment of culture. Care was also exercised to
clean the platform with 70% ethanol prior to seeding the cells and every time medium
changes took place. Glass vials were autoclaved prior to use. Similarly, after rinsing
with the varied alcohol concentrations and with ultrapure water, scaffolds were
handled carefully to prevent contamination.
4.3.3 Cell Seeding
Using the most sterile condition possible, all materials were brought inside the
biological hood to start the culture. The porous scaffolds were glued to the inner pistons
of the platform using silicone. Then, cells were seeded directly on top of the surface of
the scaffold affixed to the vial at a concentration of 106 cells per sample. The fact that
such a huge concentration of cells was utilized corresponded to efforts to boost the
chances of ECM deposition and mineralization. The cell suspension occupied 1 mL and
2 more mL of warmed +Dex media were added for a final volume of 3 mL per vial.
After seeding the cells, the scaffolds fixed to the pistons were brought to their initial
positions in contact with the seeded surface of the vial scaffold. All other parts of the
platform were assembled and the setup was housed inside the incubator. Serving as a
latency period, the culture under these stationary conditions was carried out for 2
weeks prior to simulating distraction. Regular changes of media were carried out every
two days. The platform with the seeded scaffolds can be seen in the upper image of
Figure 16. The red liquid corresponds to the +Dex medium utilized.
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Another culture was also started in a well plate where three scaffolds were glued
each to one well. Then, scaffolds were seeded by depositing the cell solution in a drop
by drop fashion. An empty well was also seeded with cells at the same concentration.
To have means of comparison, the total volume of media was set also to 3 mL per each
individual well. The static culture control is shown in the well plate in the lower image
of Figure 16.

Figure 16 - Upper: Platform for in-vitro osteodistraction. Lower:
Static culture of scaffolds to serve as control.
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4.3.4 Implementation of Distraction Steps
At the moment the cells had reached the 14th day of culture, the latency period
proposed had been finalized and it was time for the distraction osteogenesis experiment
to begin. The rate of displacement in the proposed regime needed to take into account
parameters from both the biological and medical perspectives to approximate better invivo conditions. The biological view indicates that mature osteoblast, among other
mammalian cell types, need to reside no further than 250 microns from a blood vessel to
obtain nutrients and exchange metabolic waste for their survival [98]. On the other
hand, medical literature reviewed on distraction osteogenesis protocols point to
displacement rates in the range from half to one millimeter per day [78-80] with better
consolidation of bone tissue when continuous displacement, rather than periodic, was
implemented on in-vivo animal studies [99]. With this in mind, it was decided to utilize
an intermediate value of 0.5 mm per distraction step with continuous traction over a
period of 20 hours followed by a rest phase of 24 hours. In deciding this parameter, a
heavier weight was assigned to medical protocols since it was assumed that medium
would permeate into the gap and thus fulfilling the requisite of providing nutrients and
means for metabolic exchange to cells.
After attaching the platform to the ElectroForce BioDynamic® grips, WinTest 4.1
software was used to impose a ramp curve at a rate of 6.94x10-6 mm/sec which would
translate to a time of 20 hours to complete half a millimeter. Under incubation
conditions, the experiment was allowed to run overnight and data captured every
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second for each 20 hour cycle. This setup was run four times for a total of 2 mm gap
increase overall with 24 hour rest periods in between. The graph in Figure 17 shows the
plot of distance versus time for one of the cycles carried out with measurements
condensed to one data point every ten minutes passed. The graph demonstrates the
linear behavior, due to the constant rate, imposed by the linear actuator on the
displacement.

Figure 17 - Plot of one cycle of simulated distraction. The plot shows information for a running period of 20
hours with measurements taken in cycles of 10 minutes.

After the distraction phase had been performed, the culture was allowed to rest
in a simulated consolidation stage for ten days. On day 9 of the consolidation phase,
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some scaffolds (vial and porous) were stained with xylenol orange for later
observations using microscopy. Moreover, on the last day of consolidation, an alizarin
red staining was performed on all samples to evaluate the level of mineralization and to
corroborate by visual inspection if indeed tissue had formed at the interface of scaffolds.
The methodology followed during this process is described in detail in the following
section.
4.4 ASSESSMENT OF MINERALIZATION
4.4.1 Xylenol Orange Assay
One day prior to finalizing the experiment, 3 mL of the XO fluorochrome were
added to half the vials where scaffolds had been cultured. All samples were incubated
overnight and observed the following day. To observe the surface of the porous
scaffolds, they were detached from the inner pistons and placed in a well-plate with
each in one well. Then medium was added and observations made under the
microscope. The other two samples that were not stained served as controls.
When the process of removing the inner pistons was carried out, it was seen that
no significant tissue had developed in the gap separating the scaffolds. Nonetheless,
when observed under the microscope, it was possible to identify some calcified nodules
present in the lower and lateral surfaces of porous scaffolds. Nodules of what appears
as calcified material are shown in the series of images depicted in Figure 18. To obtain
contrast, images of unstained control scaffolds are also included where marked
differences in fluorescence can be appreciated.
51

Figure 18 - Inner scaffolds observed for mineral tissue formation. The two images on the top correspond to the two
samples stained with XO. Middle section images are photographs of the boundary of stained scaffolds. The bottom
images are the controls without XO. Mineral nodules (fluorescent orange dots) are readily observed in stained
samples.
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Even though no large quantities of mineralization were detected, the
photographs demonstrate to some extent that indeed cells that were initially cultured in
the substrate of the vial scaffolds, migrated to the surface of the porous scaffolds,
attached and mineralized with concentrated mineralization in the lower surface and
around the circumference of porous scaffolds.
4.4.2 Alizarin Red Staining
Alizarin red (AR) is a dye that has been employed to detect calcium formation in
static culture and in 3-D seeded scaffolds with bone forming cells. For this experiment,
staining with AR would allow for the observation of mineralized tissue with no special
equipment.

A recipe for the preparation of an alizarin red solution (ARS) was

borrowed from [53] and is included in Appendix 1.
After observations were made using XO fluorescence, the vials were removed
from the platform and their contents stained with ARS following a method presented
by [100]. First, the scaffolds were washed three times with phosphate buffer saline (PBS)
and fixed with 10% (v/v) formalin inside a chemical fume hood at room temperature
for 15 minutes. Then, they were washed two times with ultrapure water prior to
staining with 1 mL of ARS. Scaffolds were incubated at room temperature for 20
minutes and afterwards, the excess dye removed. Finally, the samples were washed
several times with ultrapure water with gentle shaking and left at an angle for excess
water to drip. After that, the samples could be observed for signs of any stained

53

mineralized tissue. Porous scaffolds, which hung from the inner pistons, were also
stained using the same method to seek any traces of calcium at their surfaces.
Visual inspection of the stained samples indicated that no tissue developed in the
gap separating the scaffolds. As a matter of fact, after looking at pictures of the contents
of the vials, it was seen that the majority of staining occurred around the space where
porous scaffolds were resting during the simulated latency phase. As shown in the
picture below in Figure 19, the dye concentrated outwards to the wall of the glass vial
with no heavy staining in its center. Similarly, images of stained porous scaffolds were
also obtained and they indicated that most of the alizarin red dye had attached to the
lower surface and in the wall comprising their circumferential surface. This was in
agreement with the observations made of mineralized nodules by XO. Figure 19 also
includes photographs of the stained porous scaffolds in a well plate.

Figure 19 - Pictures of scaffolds stained with Alizarin Red solution.

54

4.4.3 Fluorochrome Staining of Static Controls
Similar to the experiment for biocompatibility of the material, the static controls
were also subjected to two fluorochrome analyses. This was done to have a means for
comparing mineralization of scaffolds in static conditions to scaffolds in the distraction
regime. Hence, the well plate containing the seeded scaffolds and a static culture of cells
were stained using the fluorochromes xylenol orange and calcein blue (CB) at days 14
and 21 post-confluence respectively. In this fashion, calcium deposition by cells could
be observed at two points in time with the ability to distinguish old mineralization from
new. At day 14, XO was added as described previously. Pictures were taken the next
day using microscopy. At day 21, the CB assay was performed following more or less
the same procedure; First, old culture medium was aspirated and replaced with fresh
medium. Then, 1.5 µL CB per mL of medium were added utilizing the concentration
described by [95]. Observations were made also on the following day.
The images taken on days 14 and 21 revealed that cells had indeed created some
mineralized nodules in what appears to be a soft tissue material or ECM. Figure 20
reveals this effect concentrated at the boundary of wells. Moreover, since the
fluorescence effect remains even when fluorochromes are combined, it was possible to
identify old mineral material from new. This was done on day 21 by changing the filter
through which observations were made. The following images correspond to the same
area photographed utilizing only microscopy, then the XO filter and the CB filter
afterwards. Mineralization of this soft-tissue-like material is evident.
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Figure 20 - Photographs of static cultured scaffolds. Top pictures show what appears to be soft tissue or ECM at the
boundary of the well. The middle and bottom images, taken in the same area as the top ones, point to
mineralization of tissue as seen by the XO and CB filters respectively.
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CHAPTER 5
OVERALL CONCLUSIONS AND RECOMMENDATIONS
5.1 IMPLEMENTED SETUP
This thesis focused on the development of a suitable device to replicate, in an invitro setup, the surgical procedure of distraction osteogenesis with the aim of growing
mineralized tissue in-vitro. The setup was planned for meeting all requirements of cell
culture and medicine and it proved to be appropriate for testing the formulated
hypothesis of in-vitro mineralized tissue growing. The platform constructed performed
correctly, allowing hygienic culture of cells as well as the application of linear
movement mimicking the steps of distraction osteogenesis. Further iterations on the
design of this device should consider several recommendations listed in section 5.3.
5.2 CONCLUSION OF IN-VITRO OSTEODISTRACTION
The experimentation carried out with BMSC resulted in no evident
mineralization of tissue in the structure and quantity expected. In experimental results,
seeded bone marrow stromal cells did not attach in the center of the lower vial scaffolds
since a void was present in this zone where porous scaffolds were in contact with the
surfaces of the vial scaffolds. Cells instead, attached to the exposed surfaces
(circumference and bottom) of the porous scaffolds and appeared to mineralize small
nodules in this environment. The mineralized material mostly corresponds to alkaline
phosphatase produced by cells. These results suggest that indeed there was some
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activity at the contact surfaces of scaffolds resulting in, at minimal, the migration of cells
from one scaffold to another.
From the photographs obtained of the static cultured controls, cells were
observed to form a relatively thick layer of soft tissue similar to ECM within the wells
containing them. Furthermore, the images of mineralized tissue with XO and CB
markers in Figure 20 corroborate the fact that cells are able to continuously mineralize
portions of tissue during various weeks of culture. These observations point to the
feasibility of obtaining a similar behavior under the distraction regime if different
substrates, rather than PCL are utilized as matrices to culture cells. Nonetheless, using
the current experimental setup, the expected behavior was not observed and tissue did
not develop in 3-D structures of clinically relevant amounts.
5.3 RECOMMENDATIONS FOR FUTURE WORK
Even though the experiment did not result in the formation of large quantities of
mineralized tissue, this setup has tremendous room for improvement. Some of the
recommendations for continuing this research are described next, grouped according to
particular areas identified.
5.3.1 Materials for Scaffold
This is one of the most important aspects that could be refined in future
iterations of this experiment. We strongly believe that other various materials should be
researched as scaffold materials under a similar setup. Of particular interest should be
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exploring the utilization of naturally occurring polymers like collagen or bone tissue
that has been treated with enzymes to wash away cells leaving a demineralized matrix.
5.3.2 Culture of Cells
On the static culture of cells, it was seen that they started to produce ECM and
continued mineralization of the same at about 18 days of culture. The fact that cells did
not form tissue at the interface of scaffolds might be in part to the lack of proper time to
allow tissue to first grow. As recalled from the experiment, right after cell seeding in the
vial scaffold, the porous scaffold was set in contact. Thus, after seeding the cells, a
period for ECM to be deposited might be required prior to bringing scaffolds into
contact. This inherently will require extending the period of culture.
Furthermore, the effect of culturing other cell types could also be investigated.
For the cell culture experiments of this research, BMSC were induced to the osteoblast
phenotype which might impact the rate at which cells are able to mineralize. If other
cell types such as fully mature osteoblast are utilized, rates of mineralization can be
greater enhancing the probability for success.
5.3.3 Culture Conditions
The setup utilized took into account many of the traditional factors utilized in
culture of cells, namely incubation temperature, humidity and levels of CO2. However,
future work should also concentrate on investigating the effects of the introduction of
other variables or factors to the setup. For instance, rather than solely increasing the gap
between scaffolds, a cyclic compression-tension regime which literally squeezes the
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scaffolds might improve the activity of cells and hence of mineral deposition. Of similar
interest should be the investigation of the effects that induced shear stress has on cells.
This could be achieved by re-designing the device to incorporate a perfusion bioreactor
system.
5.3.4 Material for Platform
The platform designed and constructed for experimentation had a good
performance in terms of maintaining the general hygiene of cells and providing means
of simulating the increase in the distraction gap. However, at the conclusion of the
present experiment, slight deformation–not affecting the results of this research–was
observed on some of the ABS parts such as the support bases. This might be the result
of long exposure to the temperature inside the incubator. For this reason, other stronger
materials, like aluminum or stainless steel, should be utilized to achieve more
dimensional control particularly if extended periods of culture are planned.
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APPENDIX 1 – CULTURE MEDIA PREPARATION
MINIMUM ESSENTIAL MEDIUM (Α-MEM) (SIGMA M0664-1L)


The contents of the bottle are added to ~900 mL of pure water and continuous
stirring using a magnetic stirring bar rotating at around 200 rpm. This should
form a well mixed suspension



2.2 g/L of sodium bicarbonate to a pH of 7.0. Final volume can be up to 1 L using
pure water. The medium is stored in a bottle and refrigerated to 4 °C

SUPPLEMENTED MEDIA (15% FBS) (α-MEM +DEX MEDIUM)
-Ingredients

340 mL of culture media



0.864 grams of Sodium-β-glycerophosphate (Sigma G9891- 100G)



0.02 g L-ascorbic acid (Sigma A4544 – 25G)



60 mL of FBS



0.04 mL of Dexamethasone (97%) (Sigma D4902 – 100mg)



0.4 mL of sterile antibiotic stock



0.48 mL Sterile fungizone

-Preparation

The 340 mL of culture media are poured into a bottle



After adding the Sodium-β-glycerophosphate, and L-ascorbic acid, the liquid
mixture is filtered into the bottle using autoclaved bottle-top filter



The remaining ingredients are added to the bottle. Then, the solution is mixed
well by swirling making sure formation of bubbles is kept to a minimum



The media is ready and it needs to be stored at 4 °C

* NOTE: Preparation of –Dex medium required the same steps and ingredients except
dexamethasone.
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ANTIBIOTIC STOCK
-Ingredients

10mL Normal saline (0.85%)



1.0g penicillin-G (sigma P-3032 100mg/mL)



0.5g gentamicin sulfate (Sigma G-1264)

-Preparation

Filter sterilize with syringe and a 0.2 micron filter.



Store at 4°C if used immediately



Store at -20°C to preserve efficacy for later use

FUNGIZONE


Sterile fungizone (VWR fungizone SV30078.01)



Store at -20°C after aliquating in plastic amber micro-centrifuge tubes

PREPARATION OF FLUOROCHROME SOLUTION XYLENOL ORANGE
-Ingredients

71.662 mg of Xylenol Orange



5 mL distilled water

-Preparation

Filter sterilize the solution using a 0.2 micron syringe filter



Store at room temperature
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PREPARATION OF ALIZARIN RED SOLUTION
-Ingredients

Alizarin Red powder (Sigma 122777-25G)



Distilled water



Ammonium Hydroxide

-Preparation

Using 10 mL of distilled water, 40 m-mol of AR powder were added thus
forming a 40mM solution.



Then, drops of ammonium hydroxide were carefully added while measuring the
pH of the solution.



After some mixing, and once the pH stabilized around 4.1, the alizarin red
solution was stored at room temperature until use.
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APPENDIX 2 – SAMPLE DATA FROM DISTRACTION REGIME

Time (s)

Displacement (mm)

0
60
120
180

0.000
0.025
0.050
0.075

240
300

0.100
0.124

360
420

0.150
0.175

480
540

0.200
0.225

600
660

0.249
0.275

720
780

0.300
0.325

840
900

0.350
0.375

960
1020
1080
1140
1200

0.400
0.425
0.449
0.475
0.499
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